Current Transplantation Reports

, Volume 5, Issue 3, pp 264–272 | Cite as

Perioperative Assessment and Intraoperative Core Concepts in the Complex Kidney Patient

  • Guy EfuneEmail author
  • Cynthia Wang
  • M. Susan Mandell
  • The Scientific Advisory Council of the Society for the Advancement of Transplant Anesthesia
Anesthesia and Critical Care in Transplantation (D Axelrod and M Kaufman, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Anesthesia and Critical Care in Transplantation



Life span and sense of well-being continue to improve post-transplantation in patients with end-stage kidney disease, despite referral of an older and more medically complex population for transplantation. In this issue of the journal, we review existing evidence about risk assessment in kidney transplant candidates from the perspective of the anesthesiologist. The authors explore cardiovascular assessment and risk in the context of intraoperative events that can influence short- and long-term outcomes.

Recent Findings

The number of patients referred for kidney transplantation continues to increase and has far exceeded the number of donor organs available. Many of these patients have become more complex with higher rates of congestive heart failure, diabetes, obesity, collagen vascular disease, and end organ dysfunction. The risk of cardiovascular disease in the end-stage renal disease patient is higher than the general population, and many studies have looked at identifying which patients are higher risk for a post-transplant cardiovascular event. Despite this, tests to detect and guide interventions are not sensitive enough to prevent early cardiovascular complications leading to graft loss and patient death. To address this issue, we explore the strengths and limitations of current cardiovascular risk evaluation paradigms and add information about physiological events during transplant surgery that can affect short- and long-term patient and graft outcomes.


The overall survival of patients with end-stage renal disease has improved over time, but questions persist regarding best practices in the perioperative period. The approach to preoperative evaluation needs to be coherent with anticipated physiological events that occur during surgery. Filling in these gaps in knowledge may help improve the ability to identify and mitigate risk.


Kidney transplantation Cardiovascular assessment Coronary artery disease Anesthetic considerations Intraoperative monitoring Intraoperative fluid management 


Compliance and Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

Humans and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Held PJ, McCormick F, Ojo A, Roberts JP. A cost-benefit analysis of government compensation of kidney donors. Am J Transplant. 2016;16(3):877–85. Scholar
  2. 2.
    Rocha MJ, Ferreira S, Martins LS, Almeida M, Dias L, et al. Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis. Clin Transpl. 2012;26(4):529–31. Scholar
  3. 3.
    Afkarian M, Zelnick LR, Hall YN. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA. 2016;316(6):602–10. Scholar
  4. 4.
    Dieplinger G, Everly MJ. Understanding trends and predictors of outcome in elderly renal transplant recipients: an analysis of the UNOS registry. Clin Transpl. 2013:1–11.Google Scholar
  5. 5.
    Axelrod DA, Schnitzler MA, Xiao H, Irish W, Tuttle-Newhall E, Chang SH, et al. An economic assessment of contemporary kidney transplant practice. Am J Transplant. 2018;18(5):1168–76. Scholar
  6. 6.
    National Institute of Diabetes and Digestive and Kidney Diseases, Department of Health and Human Services, Kidney Disease Statistics for the United States. Available at Last accessed March 20, 2018.
  7. 7.
    Hart A, Smith JM, Skeans MA, et al. OPTN/SRTR 2015 annual data report: kidney. Am J Transplant. 2017;17(Suppl 1):21–116. Scholar
  8. 8.
    Definition of Serious and Complex Medical Conditions; Executive Summary 1999; National Academies Press: Last access March 20,2018.
  9. 9.
    Reiss-Brennan B, Brursholz KD, Dredge C, et al. Association of integrated team-based care with health care quality, utilization, and cost. JAMA. 2016;316:826–34. Scholar
  10. 10.
    Grocott MPW, Pearse RM. Perioperative medicine: the future of anaesthesia. BJA. 2012;108:723–6. Scholar
  11. 11.
    Hart A, Weir MR, Kasiske BL. Cardiovascular risk assessment in kidney transplantation. Kidney Int. 2015;87:527–34. Scholar
  12. 12.
    Kahn MR, Fallahi A, Kim MC, Esquitin R, Robbins MJ. Coronary artery disease in a large renal transplant population: implications for management. Am J Transpl. 2011;2011(11):2665–74.CrossRefGoogle Scholar
  13. 13.
    Taber DJ, DuBay D, McGillicuddy JW, Nadig S, Bratton CF, Chavin KD, et al. Impact of the new kidney allocation system on perioperative outcomes and costs in kidney transplantation. J Am Coll Surg. 2017;224(4):585–92. Scholar
  14. 14.
    Sridhar S, Guzman-Reyes S, Gumbert SD, Ghebremichael SJ, Edwards AR, Hobeika MJ, et al. The new kidney donor allocation system and implications for anesthesiologists. Semin Cardiothorac Vasc Anesth. 2017;0:1–6. CrossRefGoogle Scholar
  15. 15.
    Wray CL. Advances in the anesthetic management of solid organ transplantation. Adv Anesth. 2017;35(1):95–117. Scholar
  16. 16.
    United States Renal Data System. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2017.Google Scholar
  17. 17.
    Delville M, Sigdel TK, Wei C, Li J, Hsieh SC, Fornoni A, et al. A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Sci Transl Med. 2014;6(256):256ra136. Scholar
  18. 18.
    Seoane-Pillado MT, Pita-Fernández S, Valdés-Cañedo F, Seijo-Bestilleiro R, Pértega-Díaz S, Fernández-Rivera C, et al. Incidence of cardiovascular events and associated risk factors in kidney transplant patients: a competing risks survival analysis. BMC Cardiovasc Disord. 2017;17(1):72. CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and Care for Noncardiac Surgery: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery Circulation. 2007:23:116(17):1971–96. Erratum in: Circulation 2008:118(9): e141–2. Doi:
  20. 20.
    • Lentine KL, Costa SP, Weir MR, Robb JF, Fleisher LA, Kasiske BL, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2012;60(5):434–80. Most current recommendations for preoperative evaluation of the kidney transplant patients. Based on recommendations from multiple consensus guidelines and supported by multiple Transplant organzations. CrossRefPubMedGoogle Scholar
  21. 21.
    Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60(24):e44–e164. Scholar
  22. 22.
    Doukky R, Fughhi I, Campagnoli T, Wassouf M, Kharouta M, Vij A, et al. Validation of a clinical pathway to assess asymptomatic renal transplant candidates using myocardial perfusion imaging. J Nucl Cardiol. 2017;
  23. 23.
    Lindley EM, Hall AK, Hess J, Abraham J, Smith B, Hopkins PN, et al. Cardiovascular risk assessment and management in prerenal transplantation candidates. Am J Cardiol. 2016;117(1):146–50. Scholar
  24. 24.
    Nygaard RM, Sirany AM, Wyman EA, Bodner J, Richardson CJ, Ney AL, et al. A clinical tool to risk stratify potential kidney transplant recipients and predict severe adverse events. Clin Transpl. 2016;30(11):1494–500. Scholar
  25. 25.
    Hoftman N, Prunean A, Dhillon A, Danovitch GM, Lee MS, Gritsch HA. Revised cardiac risk index (RCRI) is a useful tool for evaluation of perioperative cardiac morbidity in kidney transplant recipients. Transplantation. 2013;96(7):639–43. Scholar
  26. 26.
    Ozkul F, Kasim Arik M, Erbiş H, Akbaş A, Yilmaz VT, Barutcu A, et al. Left ventricle ejection fraction may predict mortality in renal transplant patients. Ren Fail. 2016;38(10):1622–5. Scholar
  27. 27.
    Felix R, Saparia T, Hirose R, Almers L, Chau Q, Jonelis T, et al. Cardiac events after kidney transplantation according to pretransplantation coronary artery disease and coronary revascularization status. Transplant Proc. 2016;48(1):65–73. Scholar
  28. 28.
    Wang LW, Fahim MA, Hayen A, Mitchell RL, Baines L, Lord S, et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev. 2011;12:CD008691. Scholar
  29. 29.
    • Wang LW, Masson P, Turner RM, Lord SW, Baines LA, Craig JC, et al. Prognostic value of cardiac tests in potential kidney transplant recipients: a systematic review. Transplantation. 2015;99(4):731–45. Large meta-analysis of 52 studies looking at non-invasive and invasive testing for CAD. Showed that non-invasive testing was as good as coronary angiography at predicting future cardiac events. However a significant number of patients with negative studies still went on to have cardiac events. CrossRefPubMedGoogle Scholar
  30. 30.
    De Lima JJ, Gowdak LH, de Paula FJ. Diagnosis and treatment of coronary artery disease in hemodialysis patients evaluated for transplant. Transplant Res. 2012;1(1):3. Scholar
  31. 31.
    Kumar N, Baker CS, Chan K, Duncan N, Malik I, Frankel A, et al. Cardiac survival after pre-emptive coronary angiography in transplant patients and those awaiting transplantation. Clin J Am Soc Nephrol. 2011 Aug;6(8):1912–9. Scholar
  32. 32.
    Yasuda K, Kasuga H, Aoyama T, Takahashi H, Toriyama T, Kawade Y, et al. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol. 2006;17(8):2322–32. Scholar
  33. 33.
    Vuurmans T, Er L, Sirker A, Djurdjev O, Simkus G, Levin A. Long-term patient and kidney survival after coronary artery bypass grafting, percutaneous coronary intervention, or medical therapy for patients with chronic kidney disease: a propensity-matched cohort study. Coron Artery Dis. 2018;29(1):8–16. Scholar
  34. 34.
    Chen YY, Wang JF, Zhang YJ, Xie SL, Nie RQ. Optimal strategy of coronary revascularization in chronic kidney disease patients: a meta-analysis. Eur J Intern Med. 2013;24(4):354–61. Scholar
  35. 35.
    Deo SV, Shah IK, Dunlay SM, Erwin PJ, Dillon JM, Park SJ. Myocardial revascularization in renal dysfunction: a systematic review and meta-analysis. Heart Lung Circ. 2013;22(10):827–35. Scholar
  36. 36.
    Charytan DM, Li S, Liu J, Herzog CA. Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease. Circulation. 2012;126(11 Suppl 1):S164–9. Scholar
  37. 37.
    Sunagawa G, Komiya T, Tamura N, Sakaguchi G, Kobayashi T, Murashita T. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis. Ann Thorac Surg. 2010;89(6):1896–900; discussion 1900. Scholar
  38. 38.
    Krishnaswami A, Goh ACH, Go AS, Lundstrom RJ, Zaroff J, Jang JJ, et al. Effectiveness of percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease. Am J Cardiol. 2016;117(10):1596–603. Scholar
  39. 39.
    Roberts JK, Rao SV, Shaw LK, Gallup DS, Marroquin OC, Patel UD. Comparative efficacy of coronary revascularization procedures for multivessel coronary artery disease in patients with chronic kidney disease. Am J Cardiol. 2017;119(9):1344–51. Scholar
  40. 40.
    Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305. Erratum in: N Engl J Med 2008;18(4):4. Scholar
  41. 41.
    Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–9.CrossRefPubMedGoogle Scholar
  42. 42.
    Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2012;143(1):4–34. Erratum in: J Thorac Cardiovasc Surg. 2012 May:143(5):1235CrossRefPubMedGoogle Scholar
  43. 43.
    Martinez BS, Gasanova I, Adesanya AO. Anesthesia for kidney transplantation—a review. J Anesth Clin Res. 2013;4:270. Scholar
  44. 44.
    Yadav R, Solanki SL. “Graded” epidural anesthesia for renal transplant in a patient with dilated cardiomyopathy and severe left ventricle systolic dysfunction. Saudi J Anaesth. 2017;11(2):222–4. Scholar
  45. 45.
    Gobbi F, al e. Low-dose spinal block with continuous epidural infusion for renal transplantation in a patient with Alport syndrome: a case report. Transplant Proc. 2016;48(9):3067–9. Scholar
  46. 46.
    Kettner SC, Willschke H, Marhofer P. Does regional anaesthesia really improve outcome? Br J Anaesth. 2011;107(Suppl 1):i90–5. Scholar
  47. 47.
    Xie S, Ma W, Guo Q, Liu J, Li W, McLeod HL, et al. The pharmacogenetics of medications used in general anesthesia. Pharmacogenomics. 2018;19(3):285–98. Scholar
  48. 48.
    Leslie K, McIlroy D, Kasza J, Forbes et al. Neuraxial block and postoperative epidural analgesia: effects on outcomes in the POISE-2 trial. Br J Anaesth 2016 Jan:116(1):100–112. doi:
  49. 49.
    De Schoenmakere G, Vanholder R, Rottey S, Duym P, Lameire N. Relationship between gastric emptying and clinical and biochemical factors in chronic haemodialysis patients. Nephrol Dial Transplant. 2001 Sep;16(9):1850–5.CrossRefPubMedGoogle Scholar
  50. 50.
    Harter RL, Kelly WB, Kramer MG, Perez CE, Dzwonczyk RR. A comparison of the volume and pH of gastric contents of obese and lean surgical patients. Anesth Analg. 1998 Jan;86(1):147–52.PubMedGoogle Scholar
  51. 51.
    Wagener G, Brentjens T. Anesthetic concerns in patients presenting with renal failure. Anesthesiol Clin. 2010 Mar;28(1):39–54. Scholar
  52. 52.
    Cantaluppi V, Quercia AD, Dellepiane S, Ferrario S, Camussi G, Biancone L. Interaction between systemic inflammation and renal tubular epithelial cells. Nephrol Dial Transplant. 2014 Nov;29(11):2004–11. Scholar
  53. 53.
    Collange O, al e. Intraoperative pleth variability index is linked to delayed graft function after kidney transplantation. Transplant Proc. 2016;48(8):2615–21. Scholar
  54. 54.
    Gingell-Littlejohn M, al e. Below-target postoperative arterial blood pressure but not central venous pressure is associated with delayed graft function. Transplant Proc. 2013;45(1):46–50. Scholar
  55. 55.
    van Diepen S, Vavalle JP, Newby LK, Clare R, Pieper KS, Ezekowitz JA, et al. The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction. Crit Care Med. 2013 Sep;41(9):2080–7. Scholar
  56. 56.
    Bennett K, Pace N. Anaesthesia for renal transplantation: an update. Anaesthesia Intensive Care Med. 2015;16(7):334–8. CrossRefGoogle Scholar
  57. 57.
    Mathias CJ. Autonomic diseases: management. J Neurol Neurosurg Psychiatry. 2003;74(Suppl 3):iii42–7.PubMedPubMedCentralGoogle Scholar
  58. 58.
    Marik PE, al e. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008;134(1):172–8. Scholar
  59. 59.
    Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med. 2013;41(7):1774–81. Scholar
  60. 60.
    Eskesen TG, a. Systematic review including re-analyses of 1148 individual data sets of central venous pressure as a predictor of fluid responsiveness. Intensive Care Med. 2016;42(3):324–32.
  61. 61.
    Bednarczyk JM, al e. Incorporating dynamic assessment of fluid responsiveness into goal-directed therapy: a systematic review and meta-analysis. Crit Care Med. 2017;45(9):1538–45. Scholar
  62. 62.
    Waldron NH, al e. Perioperative goal-directed therapy. J Cardiothorac Vasc Anesth. 2014;28(6):1635–41. Scholar
  63. 63.
    Srivastava D, al e. Effect of intraoperative transesophageal Doppler-guided fluid therapy versus central venous pressure-guided fluid therapy on renal allograft outcome in patients undergoing living donor renal transplant surgery: a comparative study. J Anesth. 2015;29(6):842–9. Scholar
  64. 64.
    Toyoda D, al e. The comparison between stroke volume variation and filling pressure as an estimate of right ventricular preload in patients undergoing renal transplantation. J Anesth. 2015;29(1):40–6. Scholar
  65. 65.
    Chin JH, al e. Can stroke volume variation be an alternative to central venous pressure in patients undergoing kidney transplantation? Transplant Proc. 2014;46(10):3363–6. Scholar
  66. 66.
    Wang C, Efune G, Mandell MS, personal communication SATA scientific committee.Google Scholar
  67. 67.
    Wald R, al e. The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study. Crit Care Med. 2014;42(4):868–77. Scholar
  68. 68.
    Adwaney A, al e. Perioperative plasma-lyte use reduces the incidence of renal replacement therapy and hyperkalemia following renal transplantation when compared with 0.9% saline: a retrospective cohort study. Clin Kidney J. 2017;10(6):838–44. Scholar
  69. 69.
    Weinberg L, al e. Effects of intraoperative and early postoperative normal saline or plasma-lyte 148 on hyperkalemia in deceased donor renal transplantation: a double-blind randomized trial. Br J Anaesth. 2017;119(4):606–15. Scholar
  70. 70.
    Hadimioglu N, al e. The effect of different crystalloid solutions on acid-base balance and early kidney function after kidney transplantation. Anesth Analg. 2008;107(1):264–9. Scholar
  71. 71.
    Wan, S, et. al. Normal saline versus lower-chloride solutions for kidney transplantation. Cochrane Database Syst Rev. 2016: (8): CD010741. Doi:
  72. 72.
    Ciapetti M, al e. Low-dose dopamine in kidney transplantation. Transplant Proc. 2009;41(10):4165–8. Scholar
  73. 73.
    Lauschke A, al e. “Low-dose” dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int. 2006;69(9):1669–74. Scholar
  74. 74.
    Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med. 2002;28(7):877–83. Scholar
  75. 75.
    Friedrich JO, al e. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med. 2005;142(7):510–24.CrossRefPubMedGoogle Scholar
  76. 76.
    Kalmar AF, Allaert S, Pletinckx P, Maes JW, Heerman J, Vos JJ, et al. Phenylephrine increases cardiac output by raising cardiac preload in patients with anesthesia induced hypotension. J Clin Monit Comput. 2018;
  77. 77.
    Day KM, Beckman RM, Machan JT, Morrissey PE. Efficacy and safety of phenylephrine in the management of low systolic blood pressure after renal transplantation. J Am Coll Surg. 2014 Jun;218(6):1207–13. Scholar
  78. 78.
    Mittel AM, Wagener G. Anesthesia for kidney and pancreas transplantation. Anesthesiology Clin. 2017;35(3):439–52. Scholar
  79. 79.
    al Yang e. Intravascular administration of mannitol for acute kidney injury prevention a systematic review and meta-analysis. PLoS One. 2014;9(1):e85029. Scholar
  80. 80.
    Shawkat H, Westwood MM, Mortimer A. Mannitol: a review of its clinical uses. Contin EducAnaesth Crit Care Pain. 2012;12:82–5.CrossRefGoogle Scholar
  81. 81.
    Andrews PM, al e. Mannitol infusion within 15 min of cross-clamp improves living donor kidney preservation. Transplantation. 2014;98(8):893–7. Scholar
  82. 82.
    Esfahani HS, al e. The effect of mannitol administration to kidney donor on short-term outcomes of kidney transplantation. Saudi J Kidney Dis Transpl. 2014;25(6):1154–9.CrossRefPubMedGoogle Scholar
  83. 83.
    Hanif F, al e. Outcome of renal transplantation with and without intra-operative diuretics. Int J Surg. 2011;9(6):460–3. Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Guy Efune
    • 1
    Email author
  • Cynthia Wang
    • 2
  • M. Susan Mandell
    • 3
  • The Scientific Advisory Council of the Society for the Advancement of Transplant Anesthesia
  1. 1.Department of Anesthesiology and Pain ManagementUT Southwestern Medical CenterDallasUSA
  2. 2.Department of Anesthesiology and Pain ManagementVA North Texas Healthcare SystemDallasUSA
  3. 3.Department of AnesthesiologyUniversity of ColoradoAuroraUSA

Personalised recommendations